Lexicon Pharmaceuticals
LXRX
LXRX
91 hedge funds and large institutions have $150M invested in Lexicon Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $214M → $150M (-$64M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
71% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 24
Holders
91
Holding in Top 10
2
Calls
$288K
Puts
$163K
Top Buyers
| 1 | +$1.44M | |
| 2 | +$863K | |
| 3 | +$708K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$525K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$480K |
Top Sellers
| 1 | -$2.5M | |
| 2 | -$944K | |
| 3 | -$909K | |
| 4 |
Morgan Stanley
New York
|
-$904K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$809K |